DataArt, the global technology consultancy that designs, develops and supports unique software solutions, announced its partnership with Health Navigator, a platform offering a comprehensive clinical vocabulary and decision-support system designed to facilitate eHealth and telemedicine encounters.

System couples the ACQUITY QDa detector with the IonSense DART ion source for rapid molecular fingerprinting of foods and food ingredients.

Bio-cannabis product pipeline ready to be commercialized In Canada.

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the launch of a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs.

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

Methods to monitor and potentially modulate the systemic response to cancer, offer new avenues for early detection, personalized medicine and therapeutic modalities.

POC testing of penKid® and bio-ADM® is set to add significant clinical benefit to emergency departments and intensive care units allowing on-site diagnosis, monitoring, and guidance in therapies of sepsis, decongestion in heart failure and acute kidney injury, thereby improving outcomes in acute heart failure, sepsis and other acute settings.

The World Health Organization recommends IGRA tests in the First Edition of Essential In Vitro Diagnostics.

Lonza has announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.

Available in 96- and 384-well configurations - Porvair Sciences reagent reservoirs are designed for simple integration into any automated liquid handling system.